Skip to content

Clinical trials

Post-Acute COVID-19 Syndrome trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Country / region: China Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
202313
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Unknown status3
Not yet recruiting2
Active, not recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Changhai Hospital1
First Affiliated Hospital Xi'an Jiaotong University1
Guangdong Provincial People's Hospital1
Haiyan Wang1
Hong Kong Baptist University1
Huashan Hospital1
Huazhong University of Science and Technology1
Lizora LLC1
Nanfang Hospital, Southern Medical University1
Peking University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome15
COVID-196
Chronic Cough2
Coronavirus Infections1
Dyspnea1
Fatigue1
Influenza, Human1
Mental Fatigue1
Reinfection1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.